Hexyl nicotinate
| Code | Size | Price |
|---|
| TAR-T20444-500mg | 500mg | £103.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20°C
Documents
Further Information
Bioactivity:
Hexyl nicotinate is a cutaneous vasodilator and can be used in research on non-immunologic contact urticaria on the scalp, face, and back.
CAS:
23597-82-2
Formula:
C12H17NO2
Molecular Weight:
207.27
Purity:
0.98
SMILES:
CCCCCCOC(c1cnccc1)=O
References
Sivamani RK, et al. Microneedle penetration and injection past the stratum corneum in humans. J Dermatolog Treat. 2009;20(3):156-9.
Zhai H, et al. Reactions of non-immunologic contact urticaria on scalp, face, and back. Skin Res Technol. 2012 Nov;18(4):436-41.
Wa CV, Maibach HI. Mapping the human face: biophysical properties. Skin Res Technol. 2010 Feb;16(1):38-54.
Uchimura T, et al. Estimation of serum protein binding of compounds metabolized in serum using matrix inhibition. Biopharm Drug Dispos. 2008 Jul;29(5):308-10.